Home / Investments / Stocks Rise as Investors Weigh Vaccine Hopes, Recovery

Stocks Rise as Investors Weigh Vaccine Hopes, Recovery

About Debra Sibley

Avatar

Check Also

Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion

The biotech drugmaker has a market value of roughly $10 billion, meaning that Gilead would …

css.php